Energy to Eye Care: Since the introduction of the first laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.
Lumenis Vision is renowned for technological breakthroughs in ophthalmic lasers and a long list of industry gold standards. Our company pioneered the first argon laser photocoagulator for ophthalmology; the first approved marketer of Nd:YAG photodisruptor lasers; developed and introduced the breakthrough technology of multicolor photocoagulation along with the world's first Laser Indirect Ophthalmoscope (LIO); developed and brought to market the revolutionary SLT technology for managing POAG, and more.
Today, Lumenis Vision offers you the confidence of doing business with a company that is truly committed to ophthalmology and to meeting your needs.
Eyelid inflammation affects millions of Indians every year. Over 85% of eyelid inflammation patients also suffer from inflammatory ocular conditions.
Lumenis invites you to think outside the eye and offer your patients a solution to their dry eye related problems with M22 OPTTM. M22TM combines Intense Pulsed Light (IPL) with unique Optimal Pulse Technology (OPTTM).
Event & Conferences at a glance
Lumenis Vision feels proud to bring to you highly informative education and trainings platforms through participation in various scientific sessions & workshops where you can learn more about our ground-breaking technologies and the opportunities they offer for your practice.
Phaco Festival 2018, Bengaluru
Lumenis participated in the event with major focus on enlightening audiences about our breakthrough & revolutionary technology for treatment of Dry Eyes. The scientific session on M22 OPT for Dry Eyes by Dr Chandanlatha from Nethradhama, Bengaluru was a big success with full house attendances. Our booth witnessed excellent interactions between doctors and Sales team.
M22 OPT Training Event
Lumenis India in collaboration with Centre for Sight organized an exclusive M22 OPT training through webinar with Dr Rolando Toyos, medical Director and Founder - Toyos Clinic who pioneered use of M22 OPT treatment for Dry Eyes. The event was held at Metropolitan Hotel, New Delhi. More than 40 doctors from Centre for Sight participated in the event and 35 doctors from other parts of India also participated through webinar.
Ojas Eye Hospital introduces Lumenis M22 OPT technology for dry eyes M22 is the answer to a majority of eye inflammation...Read More
The Eye Care Sector Is Growing And The Major Push Is Coming From The Technological Innovations Taking Place...Read More
Eye Care Is An Important Segment In The Healthcare World And Technology Is Pushing It Towards A Better Future...Read More
What Our Partners Have to Say?
Dr Mahipal S Sachdev
Chairman and Managing Director,
Centre For Sight
"Optimal Pulse Technology (OPT) is latest advance for treating dry eye. Optimal Pulse Technology is a xenon flashlamp which gives you the wavelength of 500 to 1000 nanometres. The abnormal blood vessels which are causing the inflammation of the meibomian glands get coagulated and this reduces the release of inflammatory responses which ultimately causes an improvement in the lipid secretion."
Dr Sri Ganesh
Chairman & Managing Director,
Nethradhama Hospital Pvt. Ltd
"M22 OPT has successfully reduced the symptoms of the dry eye patients giving promising results. Finally we have a very good alternative to the regular use of medications and in fact, a full stop to continuous eye drops."